728 x 90



Top Stories from

Around the World

Politicians have looked weak in the face of such natural disaster, with many facing criticism from local.

Politicians have looked weak in the face of such natural disaster, with many facing criticism from local residents for doing little more than turning up as “flood tourists” at the site of disasters, incapable of helping those in crisis and only there for a photo.

Engaging Oppurtunities

Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios nulla.

Source of Daily News

Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios nulla.

Rankings and Ratings

Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios nulla.

Our Valuable Team Members

  • Cras rutrum leo at odio volutpat id blandit fugiats?

    Engaging Oppurtunities and Top Benefits

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

    Press Office, Licensees and Employment

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

  • Donec fermentum porttitor nunc amet gravida?

    Engaging Oppurtunities and Top Benefits

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

    Press Office, Licensees and Employment

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

  • Aenean faucibus sapien a odio varius?

    Engaging Oppurtunities and Top Benefits

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

    Press Office, Licensees and Employment

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

  • Donec pulvinar lectus quis laoreet vestibulum?

    Engaging Oppurtunities and Top Benefits

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

    Press Office, Licensees and Employment

    Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.

Press Office News

  • “Delhi Schools Receive Second Bomb Threat in a Week; Authorities Investigate”
    “Delhi Schools Receive Second Bomb Threat in a Week; Authorities Investigate”

    At least six prominent schools in Delhi, including Delhi Public School (East of Kailash), Salwan School, Modern School, and Cambridge School, received bomb threats via email on Friday. This marks the second such threat in a week, creating panic among students, parents, and staff. “Explosives in School Premises”: Threat Details The email, accessed by authorities,

  • Delhi School News: Protests, Pollution, and Bomb Threats Impacting Schools
    Delhi School News: Protests, Pollution, and Bomb Threats Impacting Schools

    Delhi is currently experiencing a period of unrest with ongoing protests and rising pollution levels, creating challenges for schools and students. The Delhi Chalo protests organized by farmers from Punjab, Haryana, and Uttar Pradesh are demanding fair prices, Minimum Support Price (MSP), and agricultural reforms. These protests have caused severe traffic congestion, leading to concerns

  • Foracort Becomes Best-Selling Drug Amid Delhi’s Air Quality Crisis
    Foracort Becomes Best-Selling Drug Amid Delhi’s Air Quality Crisis

    As Delhi’s air quality continues to worsen, the demand for respiratory drugs has surged, with Foracort emerging as India’s best-selling medicine in October. The inhaler, used to treat asthma and chronic obstructive pulmonary disease (COPD), achieved Rs 75 crore in sales, surpassing well-known medications like the antibiotic Augmentin (Rs 73 crore) and the antidiabetic Glycomet-GP